SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemours Co. – ‘10-K’ for 12/31/23 – ‘EX-22’

On:  Wednesday, 3/27/24, at 4:08pm ET   ·   For:  12/31/23   ·   Accession #:  950170-24-37171   ·   File #:  1-36794

Previous ‘10-K’:  ‘10-K’ on 2/10/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   28 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  Chemours Co.                      10-K       12/31/23  200:50M                                    Donnelley … Solutions/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   8.33M 
 2: EX-10.41    Material Contract                                   HTML     65K 
 3: EX-10.43    Material Contract                                   HTML    132K 
 4: EX-21       Subsidiaries List                                   HTML     69K 
 5: EX-22       Published Report re: Matters Submitted to a Vote    HTML     57K 
                of Security Holders                                              
 6: EX-23       Consent of Expert or Counsel                        HTML     54K 
11: EX-95       Mine-Safety Disclosure                              HTML     66K 
12: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     70K 
                Awarded Compensation                                             
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     59K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     60K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     56K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     56K 
14: R1          Document and Entity Information                     HTML    129K 
15: R2          Consolidated Statements of Operations               HTML    140K 
16: R3          Consolidated Statements of Comprehensive (Loss)     HTML    168K 
                Income                                                           
17: R4          Consolidated Balance Sheets                         HTML    199K 
18: R5          Consolidated Balance Sheets (Parenthetical)         HTML     66K 
19: R6          Consolidated Statements of Stockholders' Equity     HTML    131K 
20: R7          Consolidated Statements of Stockholders' Equity     HTML     56K 
                (Parenthetical)                                                  
21: R8          Consolidated Statements of Cash Flows               HTML    176K 
22: R9          Pay vs Performance Disclosure                       HTML     67K 
23: R10         Insider Trading Arrangements                        HTML     63K 
24: R11         Background and Description of the Business          HTML     65K 
25: R12         Basis of Presentation                               HTML    237K 
26: R13         Summary of Significant Accounting Policies          HTML    147K 
27: R14         Acquisitions and Divestitures                       HTML     65K 
28: R15         Net Sales                                           HTML    238K 
29: R16         Research and Development Expense                    HTML     85K 
30: R17         Restructuring, Asset-Related, and Other Charges     HTML    416K 
31: R18         Other Income, Net                                   HTML     90K 
32: R19         Income Taxes                                        HTML    396K 
33: R20         Earnings Per Share of Common Stock                  HTML    104K 
34: R21         Accounts and Notes Receivable, Net                  HTML     99K 
35: R22         Inventories                                         HTML     80K 
36: R23         Property, Plant, and Equipment, Net                 HTML     87K 
37: R24         Leases                                              HTML    251K 
38: R25         Goodwill and Other Intangible Assets, Net           HTML    150K 
39: R26         Investments in Affiliates                           HTML    111K 
40: R27         Other Assets                                        HTML     74K 
41: R28         Accounts Payable                                    HTML   2.53M 
42: R29         Other Accrued Liabilities                           HTML     84K 
43: R30         Debt                                                HTML    320K 
44: R31         Other Liabilities                                   HTML     76K 
45: R32         Commitments and Contingent Liabilities              HTML    394K 
46: R33         Equity                                              HTML     99K 
47: R34         Stock-based Compensation                            HTML    322K 
48: R35         Accumulated Other Comprehensive Loss                HTML    109K 
49: R36         Financial Instruments                               HTML    205K 
50: R37         Long-term Employee Benefits                         HTML    406K 
51: R38         Supplemental Cash Flow Information                  HTML     75K 
52: R39         Geographic and Segment Information                  HTML    412K 
53: R40         Unaudited Quarterly Financial Information           HTML    612K 
54: R41         Summary of Significant Accounting Policies          HTML    205K 
                (Policies)                                                       
55: R42         Basis of Presentation (Tables)                      HTML    151K 
56: R43         Net Sales (Tables)                                  HTML    226K 
57: R44         Research and Development Expense (Tables)           HTML     83K 
58: R45         Restructuring, Asset-Related, and Other Charges     HTML    386K 
                (Tables)                                                         
59: R46         Other Income, Net (Tables)                          HTML     89K 
60: R47         Income Taxes (Tables)                               HTML    392K 
61: R48         Earnings Per Share of Common Stock (Tables)         HTML    106K 
62: R49         Accounts and Notes Receivable, Net (Tables)         HTML     97K 
63: R50         Inventories (Tables)                                HTML     77K 
64: R51         Property, Plant, and Equipment, Net (Tables)        HTML     82K 
65: R52         Leases (Tables)                                     HTML    254K 
66: R53         Goodwill and Other Intangible Assets, Net (Tables)  HTML    146K 
67: R54         Investments in Affiliates (Tables)                  HTML    108K 
68: R55         Other Assets (Tables)                               HTML     74K 
69: R56         Accounts Payable (Tables)                           HTML   2.53M 
70: R57         Other Accrued Liabilities (Tables)                  HTML     83K 
71: R58         Debt (Tables)                                       HTML    246K 
72: R59         Other Liabilities (Tables)                          HTML     76K 
73: R60         Commitments and Contingent Liabilities (Tables)     HTML    201K 
74: R61         Equity (Tables)                                     HTML     85K 
75: R62         Stock-based Compensation (Tables)                   HTML    289K 
76: R63         Accumulated Other Comprehensive Loss (Tables)       HTML    108K 
77: R64         Financial Instruments (Tables)                      HTML    180K 
78: R65         Long-term Employee Benefits (Tables)                HTML    395K 
79: R66         Supplemental Cash Flow Information (Tables)         HTML     74K 
80: R67         Geographic and Segment Information (Tables)         HTML    408K 
81: R68         Unaudited Quarterly Financial Information (Tables)  HTML    608K 
82: R69         Background and Description of the Business -        HTML     66K 
                Narrative (Details)                                              
83: R70         Basis of Presentation - Revised Consolidated        HTML     76K 
                Balance Sheets (Details)                                         
84: R71         Basis of Presentation - Revised Consolidated        HTML    100K 
                Statements of Cash Flows (Details)                               
85: R72         Summary of Significant Accounting Policies -        HTML    107K 
                Narrative (Details)                                              
86: R73         Acquisitions and Divestitures - Narrative           HTML     84K 
                (Details)                                                        
87: R74         Net Sales - Summary of Disaggregation of Net Sales  HTML    157K 
                by Geographical Region and Segment and Product                   
                Group (Details)                                                  
88: R75         Net Sales - Summary of Contract Balances from       HTML     62K 
                Contracts with Customers (Details)                               
89: R76         Net Sales - Narrative (Details)                     HTML     61K 
90: R77         Net Sales - Narrative (Details1)                    HTML     69K 
91: R78         Research and Development Expense - Summary of R&D   HTML     70K 
                Expense by Segment and Corporate and Other                       
                (Details)                                                        
92: R79         Restructuring, Asset-Related, and Other Charges -   HTML    147K 
                Schedule of Restructuring Program (Details)                      
93: R80         Restructuring, Asset-Related, and Other Charges -   HTML    213K 
                Narrative (Details)                                              
94: R81         Restructuring, Asset-Related, and Other Charges -   HTML     72K 
                Restructuring Program Schedule (Details)                         
95: R82         Other Income, Net - Components of Other Income      HTML     66K 
                (Details)                                                        
96: R83         Other Income, Net - Components of Other Income      HTML     69K 
                (Parenthetical) (Details)                                        
97: R84         Income Taxes - Schedule of Components of (Benefit   HTML     83K 
                from) Provision for Income Taxes (Details)                       
98: R85         Income Taxes - Components of Deferred Tax Assets    HTML     87K 
                and Liabilities (Details)                                        
99: R86         Income Taxes - Effective Income Tax Rate            HTML     96K 
                Reconciliation (Details)                                         
100: R87         Income Taxes - Effective Income Tax Reconciliation  HTML     96K  
                (Details)                                                        
101: R88         Income Taxes - Schedule of (Loss) Income before     HTML     66K  
                Income Taxes (Details)                                           
102: R89         Income Taxes - Narrative (Details)                  HTML    105K  
103: R90         Income Taxes - Summary of open tax years by         HTML     81K  
                significant jurisdiction (Details)                               
104: R91         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     73K  
105: R92         Income Taxes - Summary of Valuation Allowance       HTML     62K  
                (Details)                                                        
106: R93         Earnings Per Share of Common Stock - Schedule of    HTML     91K  
                Earnings Per Share, Basic and Diluted (Details)                  
107: R94         Earnings Per Share of Common Stock - Schedule of    HTML     56K  
                Earnings Per Share, Basic and Diluted                            
                (Parenthetical) (Details)                                        
108: R95         Earnings Per Share of Common Stock - Schedule of    HTML     60K  
                Anti-dilutive Securities Excluded from Computation               
                of Earnings Per Share (Details)                                  
109: R96         Accounts and Notes Receivable, Net - Schedule of    HTML     62K  
                Accounts and Notes Receivable (Details)                          
110: R97         Accounts and Notes Receivable, Net - Schedule of    HTML     61K  
                Accounts and Notes Receivable (Parenthetical)                    
                (Details)                                                        
111: R98         Accounts and Notes Receivable, Net - (Narrative)    HTML     62K  
                (Details)                                                        
112: R99         Accounts and Notes Receivable, Net - Schedule of    HTML     62K  
                Allowance for Doubtful Accounts (Details)                        
113: R100        Accounts and Notes Receivable, Net - Schedule of    HTML     59K  
                Allowance for Doubtful Accounts (Parenthetical)                  
                (Details)                                                        
114: R101        Inventories - Schedule of Inventories (Details)     HTML     66K  
115: R102        Inventories - Narrative (Details)                   HTML     74K  
116: R103        Property, Plant, and Equipment, Net - Summary of    HTML     74K  
                Property, Plant, and Equipment, Net (Details)                    
117: R104        Property, Plant, and Equipment, Net - Narrative     HTML     60K  
                (Details)                                                        
118: R105        Leases - Narrative (Details)                        HTML     60K  
119: R106        Leases - Schedule of Lease Assets and Lease         HTML     86K  
                Liabilities and their Balance Sheet Locations                    
                (Details)                                                        
120: R107        Leases - Schedule of Components of Company's Lease  HTML     68K  
                Cost (Details)                                                   
121: R108        Leases - Schedule of Cash Flows Related to          HTML     68K  
                Company's Leases (Details)                                       
122: R109        Leases - Schedule of Weighted-Average Terms and     HTML     65K  
                Weighted-Average Discount Rates For Company's                    
                Leases (Details)                                                 
123: R110        Leases - Schedule of Company's Lease Liabilities'   HTML    112K  
                Maturities For Next Five Years and Thereafter                    
                (Details)                                                        
124: R111        Leases - Build-to-suit Lease Obligation -           HTML     61K  
                Narrative (Details)                                              
125: R112        Leases - Summary of Future Minimum Lease Payments   HTML     74K  
                Related to Chemours Discovery Hub Financing                      
                Obligation (Detail)                                              
126: R113        Goodwill and Other Intangible Assets, Net -         HTML     67K  
                Schedule of Goodwill (Details)                                   
127: R114        Goodwill and Other Intangible Assets, Net -         HTML     85K  
                Narrative (Details)                                              
128: R115        Goodwill and Other Intangible Assets, Net -         HTML     80K  
                Schedule of Other Intangible Assets (Details)                    
129: R116        Investments in Affiliates - Narrative (Details)     HTML     69K  
130: R117        Investments in Affiliates - Schedule of             HTML     72K  
                Investments in Affiliates (Details)                              
131: R118        Investments in Affiliates - Schedule of Changes in  HTML     66K  
                Investments in Affiliates (Details)                              
132: R119        Other Assets - Schedule of Other Assets (Details)   HTML     65K  
133: R120        Accounts Payable - Schedule of Accounts Payable     HTML     61K  
                (Details)                                                        
134: R121        Accounts Payable - Schedule Of Outstanding          HTML     65K  
                Obligation (Details)                                             
135: R122        Accounts Payable - Narrative (Details)              HTML     60K  
136: R123        Other Accrued Liabilities - Schedule of Other       HTML     75K  
                Accrued Liabilities (Details)                                    
137: R124        Other Accrued Liabilities - Schedule of Other       HTML     58K  
                Accrued Liabilities (Parenthetical) (Details)                    
138: R125        Debt - Components of Debt (Details)                 HTML    110K  
139: R126        Debt - Components of Debt (Parenthetical)           HTML     88K  
                (Details)                                                        
140: R127        Debt - Senior Secured Credit Facilities -           HTML    149K  
                Narrative (Details)                                              
141: R128        Debt - Senior Unsecured Notes - Narrative           HTML    201K  
                (Details)                                                        
142: R129        Debt - Note Repurchases - Narrative (Details)       HTML     65K  
143: R130        Debt - Accounts Receivable Securitization Facility  HTML     70K  
                - Narrative (Details)                                            
144: R131        Debt - Maturities and Fair Value - Narrative        HTML     75K  
                (Details)                                                        
145: R132        Debt - Schedule of Debt Principal Maturities        HTML    150K  
                (Details)                                                        
146: R133        Debt - Estimated Fair Values of Senior Debt Issues  HTML    117K  
                (Details)                                                        
147: R134        Debt - Estimated Fair Values of Senior Debt Issues  HTML     86K  
                (Parenthetical) (Details)                                        
148: R135        Other Liabilities - Schedule of Other Liabilities   HTML     65K  
                (Details)                                                        
149: R136        Other Liabilities - Schedule of Other Liabilities   HTML     56K  
                (Parenthetical) (Details)                                        
150: R137        Commitments and Contingent Liabilities - Summary    HTML     70K  
                of Asset Retirement Obligations (Details)                        
151: R138        Commitments and Contingent Liabilities - Schedule   HTML     68K  
                of Components of Accrued Litigation (Details)                    
152: R139        Commitments and Contingent Liabilities - Schedule   HTML     67K  
                of Current and Long-term Components of Accrued                   
                Litigation and Balance Sheet Locations (Details)                 
153: R140        Commitments and Contingent Liabilities -            HTML    248K  
                Litigation - Narrative (Details)                                 
154: R141        Commitments and Contingent Liabilities -            HTML    102K  
                Litigation - Memorandum of Understanding (MOU)                   
                with DuPont, Corteva and EID (Details)                           
155: R142        Commitments and Contingent Liabilities -            HTML     62K  
                Litigation - Asbestos (Details)                                  
156: R143        Commitments and Contingent Liabilities -            HTML     73K  
                Litigation - PFOA - Leach Settlement (Details)                   
157: R144        Commitments and Contingent Liabilities - Schedule   HTML     81K  
                of Environmental Remediation Liabilities (Details)               
158: R145        Commitments and Contingent Liabilities - Schedule   HTML     60K  
                of Environmental Remediation Liabilities                         
                (Parenthetical) (Details)                                        
159: R146        Commitments and Contingent Liabilities - Schedule   HTML     64K  
                of Current and Long-term Components of                           
                Environmental Remediation Liabilities (Details)                  
160: R147        Commitments and Contingent Liabilities -            HTML    136K  
                Environmental - Narrative (Details)                              
161: R148        Commitments and Contingent - Schedule of On-Site    HTML     68K  
                and Off-Site Components of Accrued Environmental                 
                Remediation Liabilities Related to PFAS (Details)                
                (Details)                                                        
162: R149        Commitments and Contingent Liabilities - Schedule   HTML     70K  
                of Current and Long-term Components of Accrued                   
                Environmental Remediation Liabilities (Details)                  
163: R150        Equity - Narrative (Details)                        HTML     85K  
164: R151        Equity - Schedule of Share Repurchase Activity      HTML     71K  
                (Details)                                                        
165: R152        Stock-based Compensation - Narrative (Details)      HTML    151K  
166: R153        Stock-based Compensation - Schedule of Weighted     HTML     81K  
                Average Assumptions of Stock Options (Details)                   
167: R154        Stock-based Compensation - Stock Option Activity    HTML    108K  
                (Details)                                                        
168: R155        Stock-based Compensation - Restricted Stock Units   HTML     80K  
                Activity (Details)                                               
169: R156        Stock-based Compensation - Performance Share Units  HTML     80K  
                Activity (Details)                                               
170: R157        Accumulated Other Comprehensive Loss - Schedule of  HTML     80K  
                Accumulated Other Comprehensive Loss (Details)                   
171: R158        Financial Instruments - Narrative (Details)         HTML    132K  
172: R159        Financial Instruments - Schedule of Derivative      HTML     77K  
                Assets and Liabilities At Fair Value (Details)                   
173: R160        Financial Instruments - Schedule of Pre-tax Charge  HTML     80K  
                Fair Value of Financial Instruments (Details)                    
174: R161        Long-term Employee Benefits (Narrative) (Details)   HTML    104K  
175: R162        Long-term Employee Benefits (Schedule of Net        HTML    108K  
                Periodic Pension (Cost) Income and Amounts                       
                Recognized in Other Comprehensive Income (Loss)                  
                (Details)                                                        
176: R163        Long-term Employee Benefits (Amounts Recognized in  HTML     65K  
                Accumulated Other Comprehensive Loss) (Details)                  
177: R164        Long-term Employee Benefits (Change in Benefit      HTML    107K  
                Obligation and Plan Assets) (Details)                            
178: R165        Long-term Employee Benefits (Amounts Recognized in  HTML     72K  
                Balance Sheet) (Details)                                         
179: R166        Long-term Employee Benefits (Summary of Projected   HTML     74K  
                Benefit Obligations and Accumulated Benefit                      
                Obligations in Excess of Plan Assets) (Details)                  
180: R167        Long-term Employee Benefits (Assumptions)           HTML     70K  
                (Details)                                                        
181: R168        Long-term Employee Benefits (Plan Assets)           HTML    107K  
                (Details)                                                        
182: R169        Long-term Employee Benefits (Cash Flows Defined     HTML     77K  
                Benefit Plans) (Details)                                         
183: R170        Supplemental Cash Flow information -                HTML     65K  
                Reconciliation of Cash, Cash Equivalents,                        
                Restricted Cash and Restricted Cash Equivalents                  
                (Details)                                                        
184: R171        Geographic and Segment Information - Schedule of    HTML     79K  
                Net Sales and Property, Plant and Equipment, Net                 
                by Geographical Area (Details)                                   
185: R172        Geographic and Segment Information - Narrative      HTML     56K  
                (Details)                                                        
186: R173        Geographic and Segment Information - Schedule of    HTML    118K  
                Segment Information (Details)                                    
187: R174        Geographic and Segment Information - Summary of     HTML     75K  
                Reconciliation for Summary Financial Information                 
                for Reportable Segments (Details)                                
188: R175        Geographic and Segment Information -                HTML    109K  
                Reconciliation of Segment Adjusted EBITDA from                   
                Segments to Consolidated Income (Loss) Before                    
                Income Taxes (Details)                                           
189: R176        Geographic and Segment Information -                HTML     92K  
                Reconciliation of Segment Adjusted EBITDA from                   
                Segments to Consolidated Income (Loss) Before                    
                Income Taxes (Details) (Parenthetical) (Details)                 
190: R177        Unaudited Quarterly Financial Information -         HTML    107K  
                Summary of Quarterly Results of Operations                       
                (Details)                                                        
191: R178        Unaudited Quarterly Financial Information -         HTML     58K  
                Additional Information (Details)                                 
192: R179        Unaudited Quarterly Financial Information -         HTML    140K  
                Summary of Revised Interim Consolidated Statements               
                of Operations (Unaudited) (Details)                              
193: R180        Unaudited Quarterly Financial Information -         HTML     91K  
                Summary of Revised Interim Consolidated Statements               
                of Comprehensive (Loss) Income (Unaudited)                       
                (Details)                                                        
194: R181        Unaudited Quarterly Financial Information -         HTML    113K  
                Summary of Revised Interim Consolidated Balance                  
                Sheets (Unaudited) (Details)                                     
195: R182        Unaudited Quarterly Financial Information -         HTML    154K  
                Summary of Revised Interim Consolidated Statements               
                of Cash Flows (Unaudited) (Details)                              
197: XML         IDEA XML File -- Filing Summary                      XML    402K  
200: XML         XBRL Instance -- cc-20231231_htm                     XML  17.23M  
196: EXCEL       IDEA Workbook of Financial Report Info              XLSX    491K  
13: EX-101.SCH  XBRL Taxonomy Extension Schema With Embedded         XSD  10.71M 
                Linkbases Document -- cc-20231231                                
198: JSON        XBRL Instance as JSON Data -- MetaLinks            1,200±  2.00M  
199: ZIP         XBRL Zipped Folder -- 0000950170-24-037171-xbrl      Zip   1.28M  


‘EX-22’   —   Published Report re: Matters Submitted to a Vote of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-22  

 

Exhibit 22

LIST OF GUARANTOR SUBSIDIARIES

As of December 31, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.000% senior unsecured notes due May 2026, which are denominated in euros and the 5.375% senior unsecured notes due May 2027 (collectively, the “Registered Notes”,) which are registered under the Securities Act of 1933, as amended.

 

Name

 

Organized Under Laws Of

First Chemical Holdings, LLC

 

Mississippi

First Chemical Texas, L.P.

 

Delaware

FT Chemical, Inc.

 

Texas

The Chemours Company FC, LLC

 

Delaware

 

 



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/27/24
For Period end:12/31/23NT 10-K
 List all Filings 


28 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/24  Chemours Co.                      8-K:5,9     3/22/24   12:221K                                   Donnelley … Solutions/FA
 8/23/23  Chemours Co.                      8-K:1,2,9   8/18/23   11:3.3M                                   Donnelley … Solutions/FA
 6/30/23  Chemours Co.                      8-K:1,9     6/30/23   23:3.2M                                   Donnelley … Solutions/FA
10/26/22  Chemours Co.                      10-Q        9/30/22  129:21M                                    Donnelley … Solutions/FA
 8/22/22  Chemours Co.                      8-K:5,9     8/19/22   12:444K                                   ActiveDisclosure/FA
 8/18/21  Chemours Co.                      8-K:1,2,8,9 8/18/21   14:638K                                   Donnelley … Solutions/FA
 7/26/21  Chemours Co.                      8-K:1,8,9   7/26/21   12:1.4M                                   ActiveDisclosure/FA
 7/13/21  Chemours Co.                      8-K:8,9     7/13/21   12:402K                                   ActiveDisclosure/FA
 6/03/21  Chemours Co.                      8-K:5,9     6/02/21   12:384K                                   ActiveDisclosure/FA
 3/02/21  Chemours Co.                      8-K:5,9     3/01/21   11:320K                                   ActiveDisclosure/FA
 1/22/21  Chemours Co.                      8-K:1,2,8,9 1/21/21   12:523K                                   ActiveDisclosure/FA
11/27/20  Chemours Co.                      8-K:1,2,8,911/27/20   16:1.3M                                   Donnelley … Solutions/FA
 2/14/20  Chemours Co.                      10-K       12/31/19  194:44M                                    ActiveDisclosure/FA
 6/06/18  Chemours Co.                      8-K:1,2,8,9 6/06/18    8:749K                                   Toppan Merrill/FA
 5/04/18  Chemours Co.                      10-Q        3/31/18  116:18M                                    ActiveDisclosure/FA
 8/25/17  Chemours Co.                      8-K:1,9     8/24/17    2:72K                                    ActiveDisclosure/FA
 5/23/17  Chemours Co.                      8-K:8,9     5/23/17   12:1.1M                                   Toppan Vite NY Inc./FA
 5/01/17  Chemours Co.                      8-K:5,9     5/01/17    3:423K                                   ActiveDisclosure/FA
 2/17/17  Chemours Co.                      10-K       12/31/16  160:31M                                    ActiveDisclosure/FA
 2/25/16  Chemours Co.                      10-K       12/31/15  140:14M
 2/23/16  Chemours Co.                      8-K:1,9     2/23/16    3:198K
11/05/15  Chemours Co.                      10-Q        9/30/15  106:9.6M
 8/06/15  Chemours Co.                      10-Q        6/30/15  100:8M
 7/01/15  Chemours Co.                      8-K:1,5,8,9 6/26/15   10:1.5M                                   Donnelley … Solutions/FA
 7/01/15  Chemours Co.                      S-8         7/01/15    4:122K                                   Donnelley … Solutions/FA
 7/01/15  Chemours Co.                      S-8         7/01/15    4:75K                                    Donnelley … Solutions/FA
 7/01/15  Chemours Co.                      S-8         7/01/15    4:162K                                   Donnelley … Solutions/FA
 5/13/15  Chemours Co.                      10-12B/A              15:5.7M                                   Donnelley … Solutions/FA
Top
Filing Submission 0000950170-24-037171   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 11:11:16.2am ET